TNBI
Tanke Biosciences Corp
Price:  
0.04 
USD
Volume:  
29,690
China | Manufacturing

TNBI WACC - Weighted Average Cost of Capital

The WACC of Tanke Biosciences Corp (TNBI) is 38.8%.

The Cost of Equity of Tanke Biosciences Corp (TNBI) is 10.7%.
The Cost of Debt of Tanke Biosciences Corp (TNBI) is 51.65%.

RangeSelected
Cost of equity5.7% - 15.7%10.7%
Tax rate8.2% - 19.3%13.75%
Cost of debt7.0% - 96.3%51.65%
WACC6.4% - 71.3%38.8%
WACC

TNBI WACC calculation

CategoryLowHigh
Long-term bond rate3.9%4.4%
Equity market risk premium4.6%5.6%
Adjusted beta0.41.94
Additional risk adjustments0.0%0.5%
Cost of equity5.7%15.7%
Tax rate8.2%19.3%
Debt/Equity ratio
8.648.64
Cost of debt7.0%96.3%
After-tax WACC6.4%71.3%
Selected WACC38.8%

TNBI's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for TNBI:

cost_of_equity (10.70%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.4) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.